HairDX, LLC Launches European Subsidiary To Expand Global Availability Of Genetic Baldness Test For Men And Women
IRVINE, Calif. AND HASSELT, Belgium--(BUSINESS WIRE)--Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC, pioneers of genetic tests for predicting the risk of male and female hair loss, today announced the launch of its European subsidiary, HairDX Europe.